drugset / Trial / NCT06379724
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
RandomizedParallel-groupSingle-blindTreatment
Summary
Investigators hypothesize that topical tranexamic acid will have better or comparable efficacy to topical thrombin in reducing hematoma formation at the wound base. The purpose of the study is to demonstrate that topical tranexamic acid will be a non-inferior alternative medication to the current standard of care,THROMBIN-JMI® , and at a lower cost to the health system.
Timeline
- Start
- 2024-07-11
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bovine Thrombin | Protein / enzyme biologic | — | Topical |
| Subject | Tranexamic Acid | Small molecule | 100 mg/ml | Topical |
Indications
No indication recorded.